Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)

Circulation. 2016 Sep 13;134(11):835-7. doi: 10.1161/CIRCULATIONAHA.116.023743.

¹ From Unit of Cardiovascular Science, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy (F.M., E.P., I.C., E.R., G.D.S.); Unit of Endocrinology and Diabetes, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy (A.L.P., P.P.); Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium (E.B.); and Departement of Advanced Biomedical Sciences, University of Naples Federico II, Italy (E.B.). f.mangiacapra@unicampus.it.
² From Unit of Cardiovascular Science, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy (F.M., E.P., I.C., E.R., G.D.S.); Unit of Endocrinology and Diabetes, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy (A.L.P., P.P.); Cardiovascular Research Center Aalst, OLV Hospital, Aalst, Belgium (E.B.); and Departement of Advanced Biomedical Sciences, University of Naples Federico II, Italy (E.B.).

No abstract available

Keywords: diabetes mellitus; endothelium; platelet aggregation inhibitors.

Publication types